EZH2在肿瘤组织中的表达模式与SIRT7 ... Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries ...

The study, published Dec. 5 in Cancer Cell, found that EZH2 inhibition combined with T-cell based immunotherapy worked better at shrinking non-Hodgkin B-cell lymphomas than immunotherapy alone.

The inhibitors target the EZH2 enzyme, whose activity in tumor cells is now recognized as a significant factor in many cancers. The study, published Dec. 5 in Cancer Cell, found that EZH2 ...

The cancer is also more common in the Caribbean ... "As the first dual inhibitor of EZH1 and EZH2 to receive regulatory approval anywhere in the world, Ezharmia represents an important advancement ...

The revamp of French drugmaker Ipsen has continued with a takeover agreement for US counterpart Epizyme and its cancer therapy Tazverik ... whose tumours have an EZH2 mutation.